May 26, 2021
News, notes and other things
While the FDA continues to deal with the backlog created by Covid things in Europe seem to be moving a bit quicker. Today Medtronic announced they have obtained CE marks for their Guardian 4 sensor plus expanded functionality for their InPen system. Per a company issued press release;
“Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Mark for expanded functionality of the company's InPen™ smart2 insulin pen for multiple daily injections (MDI). The company also announced CE Mark for its Guardian™ 4 sensor3, which requires no fingersticks1 for calibration . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
